Соединенные Штаты - английский - NLM (National Library of Medicine)

avpak - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - a dental caries preventive, for once daily self-applied topical use. it is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators. sodium fluoride 1.1% gel in a squeeze-tube is easily applied onto a toothbrush as well as a mouthpiece tray. this prescription dental gel should be used once daily following use of a regular toothpaste unless otherwise instructed by your dental professional. may be used whether or not drinking water is fluoridated since topical fluoride cannot produce fluorosis. (see warnings for exception.) do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - sodium fluoride 2.73%{relative} (2.88%w/w with 6% manufacturers overage.) - topical gel - 2.73% w/w - active: sodium fluoride 2.73%{relative} (2.88%w/w with 6% manufacturers overage.) excipient: carbomer 940 pascal red. flavour enhancer western. 5916-57 fruit mix flavour 53299-93 methyl salicylate phosphoric acid purified water saccharin sodium sodium benzoate vanilla flavour ke 21856

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) - topical gel - 2.73% w/w - active: sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) excipient: brilliant blue fcf carbomer 940 pascal red. enhancer flavour 5916-57 grape flavour 51125-107 phosphoric acid purified water saccharin sodium sodium benzoate

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) - topical gel - 2.73% w/w - active: sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) excipient: carbomer 940 pascal green . peppermint flavour 5873-57 phosphoric acid purified water saccharin sodium sodium benzoate spearmint oil

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) - topical gel - 2.73% w/w - active: sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) excipient: brilliant blue fcf carbomer 940 pascal red. enhancer flavour 5916-57 phosphoric acid purified water raspberry flavour 52464-121 saccharin sodium sodium benzoate vanilla flavour ke 21856

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) - topical gel - 2.73% w/w - active: sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) excipient: allura red ac carbomer 940 pascal red #33 enhancer flavour 5916-57 phosphoric acid purified water saccharin sodium sodium benzoate strawberry flavour 51870-33 vanilla flavour ke 21856

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

ivoclar vivadent ltd - sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) - topical gel - 2.73% w/w - active: sodium fluoride 2.73%{relative} (2.88% with 6% manufacturers overage.) excipient: carbomer 940 deep orange.47450 enhancer flavour 5916-57 orange flavour (creamsicle) 51445-53 phosphoric acid purified water quinoline yellow saccharin sodium sodium benzoate vanilla flavour ke 21856 zinc oxide

Соединенные Штаты - английский - NLM (National Library of Medicine)

global isotopes, llc d/b/a zevacor molecular - fluoride ion f-18 (unii: 4m4we5n2ge) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 10 mci in 1 ml - sodium fluoride f18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk.  because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium

Соединенные Штаты - английский - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.5 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 6 years of age when the fluoride content of drinking water is 0.3 ppm f* or to pediatric patients under age 3 years. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.

Соединенные Штаты - английский - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.25 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 3 years of age when the fluoride content of drinking water is 0.3 ppm f* or more. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.